![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Active Filter(s):
Details:
Recipharm is developing and commercializing inhalation technologies and products in support of the development and advancement of Transpire Bio’s TRB-1 and TRB-2 respiratory products.
Lead Product(s): TRB-1
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: TRB-1
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: Recipharm AB
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 14, 2022